VERONICA M PATTERSON

Allopathic & Osteopathic Physicians|Family Medicine COMMERCE, GA NPI 1962408997

General Payments — all program years on this page

$7,084.21

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 422
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $765.05 across 42 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $765.0542

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,280.9982
2019 $1,113.5573
2020 $782.4733
2021 $954.7967
2022 $1,066.5857
2023 $1,120.7868
2024 $765.0542

Records — PY2024 (42)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096624703 Novo Nordisk Inc $33.22 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096655398 Novo Nordisk Inc $23.47 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096810301 Novo Nordisk Inc $19.77 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096878831 Novo Nordisk Inc $23.01 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096902581 Novo Nordisk Inc $22.53 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097004956 Novo Nordisk Inc $18.46 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097093656 Novo Nordisk Inc $23.09 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097167893 Novo Nordisk Inc $16.88 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097696271 Novo Nordisk Inc $16.17 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097825796 Novo Nordisk Inc $20.49 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104329254 AstraZeneca Pharmaceuticals LP $17.64 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105212848 ABBVIE INC. $6.58 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105212852 ABBVIE INC. $14.62 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105212856 ABBVIE INC. $13.84 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105212860 ABBVIE INC. $16.81 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105212864 ABBVIE INC. $15.94 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105212868 ABBVIE INC. $10.03 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105212872 ABBVIE INC. $15.59 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105212876 ABBVIE INC. $8.68 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105212880 ABBVIE INC. $30.86 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105212884 ABBVIE INC. $8.90 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105212888 ABBVIE INC. $11.78 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114828539 Exact Sciences Corporation $18.05 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116031417 GlaxoSmithKline, LLC. $15.78 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116404795 GlaxoSmithKline, LLC. $14.46 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117651426 Amgen Inc. $21.17 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117651428 Amgen Inc. $19.02 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118251515 Boehringer Ingelheim Pharmaceuticals, Inc. $19.14 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118959409 Otsuka America Pharmaceutical, Inc. $24.54 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118959411 Otsuka America Pharmaceutical, Inc. $17.36 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118959413 Otsuka America Pharmaceutical, Inc. $22.70 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118959415 Otsuka America Pharmaceutical, Inc. $15.90 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132088607 PFIZER INC. $15.95 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135440143 Lilly USA, LLC $16.48 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135451785 Lilly USA, LLC $15.92 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135451787 Lilly USA, LLC $24.78 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135506390 Lilly USA, LLC $16.87 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147283230 Mylan Specialty L.P. $20.99 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147315728 Mylan Specialty L.P. $21.56 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147344094 Mylan Specialty L.P. $14.36 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147369957 Mylan Specialty L.P. $22.25 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153342619 Dexcom, Inc. $19.41 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.